AWH
Aspira Women's Health Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.08
−15.90%Jul 15, 2026, 00:00 UTC
Aspira Women's Health Inc. signed a $1,050,000 subordinated secured term loan due January 26, 2027, under a Subordinated Business Loan and Security Agreement with Agile Lending, LLC and Agile Capital Funding, LLC, using proceeds to refinance existing debt and for general corporate purposes.
Jul 7, 2026, 00:00 UTC
Michael Buhle resigned as Chief Executive Officer of Aspira Women's Health Inc., effective June 17, 2026.
Jun 9, 2026, 00:00 UTC
Aspira Women's Health Inc. completed a private placement of 3,300,000 shares of common stock and warrants for up to 4,455,000 additional shares, raising approximately $1.485 million in gross proceeds.